min Sekce: Daily overview

Selection from Decision-Making Practice - 3

Health Insurance Companies' Statement on the Unacceptability of Budget Impact.
Pharmeca a.s. 03/19/2025
min Sekce: Daily overview

Selection from Decision-Making Practice - 2

The State Institute for Drug Control questioned the cost-effectiveness presented in the administrative proceedings.
Pharmeca a.s. 03/12/2025
min Sekce: Daily overview

Selection from Decision-Making Practice

Multiple reimbursement levels for JAKi in reimbursement review.
Pharmeca a.s. 03/05/2025
min Sekce: Daily overview

EMA Launches New Platform to Monitor Medicine Shortages

The European Medicines Agency (EMA) has announced the launch of a new platform designed to routinely monitor shortages of centrally authorized medicines.
Pharmeca a.s. 01/31/2025
min Sekce: Data visualization

Decisions of the State Institute for Drug Control and the Ministry of Health of the Czech Republic in the Area of Pricing and Reimbursement

From January 1, 2025, Pharmeca a.s. offers an overview of SÚKL and Ministry of Health decisions on pricing and reimbursement.
Pharmeca a.s. 01/08/2025
min Sekce: Daily overview

Czech legislation

Current overview of selected Czech legal regulations regarding medicines and medical devices.
Pharmeca 01/02/2025
min Sekce: Focused on

EMA Launches New Platform to Monitor Medicine Shortages

The European Medicines Agency (EMA) has announced the launch of a new platform designed to routinely monitor shortages of centrally authorized medicines.
Pharmeca a.s. 12/16/2024
min Sekce: Focused on

European Health Data Space 2024 update

The European Health Data Space (EHDS) has advanced significantly since the initial concept of a digital transformation in healthcare across all EU member states.
Pharmeca 11/18/2024